Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients With Inflammatory Bowel Disease

Detalles Bibliográficos
Autores principales: Pozdnyakova, VALERIYA, Botwin, GREGORY J., Sobhani, KIMIA, Prostko, JOHN, Braun, JONATHAN, Mcgovern, DERMOT P.B., Melmed, GIL Y., Appel, Keren, Banty, Andrea, Feldman, Edward, Ha, Christina, Kumar, Rashmi, Lee, Susie, Rabizadeh, Shervin, Stein, Theodore, Syal, Gaurav, Targan, Stephan, Vasiliauskas, Eric, Ziring, David, Debbas, Philip, Hampton, Melissa, Mengesha, Emebet, Stewart, James L., Frias, Edwin C., Cheng, Susan, Ebinger, Joseph, Figueiredo, Jane C., Boland, Brigid, Charabaty, Aline, Chiorean, Michael, Cohen, Erica, Flynn, Ann, Valentine, John, Fudman, David, Horizon, Arash, Hou, Jason, Hwang, Caroline, Lazarev, Mark, Lum, Donald, Fausel, Rebecca, Reddy, Swapna, Mattar, Mark, Metwally, Mark, Ostrov, Arthur, Parekh, Nimisha, Raffals, Laura, Sheibani, Sarah, Siegel, Corey, Wolf, Douglas, Younes, Ziad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the AGA Institute 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359492/
https://www.ncbi.nlm.nih.gov/pubmed/34391771
http://dx.doi.org/10.1053/j.gastro.2021.08.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359492/
https://www.ncbi.nlm.nih.gov/pubmed/34391771
http://dx.doi.org/10.1053/j.gastro.2021.08.014

Ejemplares similares